Endometrial Cancers With Activating KRas Mutations Have Activated Estrogen Signaling and Paradoxical Response to MEK Inhibition.
about
Endometrial Cancers With Activating KRas Mutations Have Activated Estrogen Signaling and Paradoxical Response to MEK Inhibition.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Endometrial Cancers With Activ ...... al Response to MEK Inhibition.
@en
Endometrial Cancers With Activ ...... al Response to MEK Inhibition.
@nl
type
label
Endometrial Cancers With Activ ...... al Response to MEK Inhibition.
@en
Endometrial Cancers With Activ ...... al Response to MEK Inhibition.
@nl
prefLabel
Endometrial Cancers With Activ ...... al Response to MEK Inhibition.
@en
Endometrial Cancers With Activ ...... al Response to MEK Inhibition.
@nl
P2093
P2860
P1476
Endometrial Cancers With Activ ...... cal Response to MEK Inhibition
@en
P2093
Joseph Celestino
Karen H Lu
Kari L Ring
Melinda S Yates
Michaela Onstad
Qian Zhang
Rosemarie Schmandt
P2860
P304
P356
10.1097/IGC.0000000000000960
P577
2017-06-01T00:00:00Z